Evidence map›Paper›PMID 42509224›Full record

ArticleCell discovery2026

Perifollicular stromal cells sustain folliculogenesis via MDK-NCL signaling in mice and humans.

Zhe Zhang, Na Kong, Jie Mei, Xiaoqiang Sheng, Jidong Zhou, Haiquan Wang, Nannan Kang, Yang Zhang, Lina Yu, Pengfei Xu and 8 more

Abstract read
In one paragraph

Article in Cell discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Zhe Zhang *Department of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Na Kong *Department of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Jie Mei *Department of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.ORCID http://orcid.org/0000-0002-5182-5059
Xiaoqiang Sheng *Department of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Jidong ZhouDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Haiquan WangDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Nannan KangDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Yang ZhangDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Lina YuDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Pengfei XuDepartment of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Xin ZhenDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Min WuDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Lijun DingDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.ORCID http://orcid.org/0000-0002-6330-7945
Guangyi CaoDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China.
Dake LiDepartment of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. dkli@njmu.edu.cn.
Chaojun LiState Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China. lichaojun@njmu.edu.cn.
Guijun YanDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China. yanguijun@nju.edu.cn.
Haixiang SunDepartment of Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, China. haixiang_sun@nju.edu.cn.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82330050National Natural Science Foundation of China (National Science Foundation of China) 82371680National Natural Science Foundation of China (National Science Foundation of China) 82471703National Natural Science Foundation of China (National Science Foundation of China) 82501966
6 · The paper itself

Abstract

Oocyte development requires coordinated metabolic and signaling support from granulosa and theca cells. By performing integrated single-cell RNA sequencing and spatial transcriptomic analyses of murine and human ovaries, we discovered a functionally specialized stromal subtype essential for folliculogenesis. These stromal cells (SCs) with glutamyl aminopeptidase (ENPEP) function, designated perifollicular SCs based on their circumferential follicle localization, exhibit two hallmark features: (1) dynamic proliferation synchronized with follicular maturation from primary to secondary to antral stages, and (2) secretion of midkine (MDK), which activates nucleolin (NCL) receptor signaling to drive granulosa cell (GC) expansion. Furthermore, analyses of ovarian aging revealed the concurrent depletion of perifollicular SCs and the attenuation of MDK-NCL signaling between perifollicular SCs and GCs. The unique spatial confinement and regulatory capacity of perifollicular SCs endow them with the potential to become important components of the follicular functional unit, providing new theoretical support for understanding the molecular regulatory mechanisms of ovarian aging from the perspective of the follicular microenvironment.

Identifiers

PMID42509224
PMCPMC13408105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.